OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
8.16
-0.03 (-0.37%)
Dec 27, 2024, 4:00 PM EST - Market closed
OnKure Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OnKure Therapeutics stock have an average target of 36, with a low estimate of 33 and a high estimate of 40. The average target predicts an increase of 341.18% from the current stock price of 8.16.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OKUR stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 1 |
| Buy | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $33 | Buy | Initiates | $33 | +304.41% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +390.20% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +390.20% | Oct 17, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $35 | Buy | Initiates | $35 | +328.92% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.